Bortezomib, a yellow solid chemical, trade name: Vanke? Velcade?, Chinese alias: mg-341; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; bortezomib impurity; Bortezomib, melting point: 122-124 ° C, molecular formula: c19h25bn4o4, molecular weight : 384.23700, this product can be used in combination with melphalan and prednisone (MP regimen) in the treatment of previously untreated multiple myeloma patients who are not suitable for high-dose chemotherapy and myelosuppression; or single drug for the treatment of multiple myeloma patients who have received at least one or more treatments; this product can be used for the treatment of patients with recurrent or refractory mantle cell lymphoma The patient has received at least one treatment before using this product. The safety and efficacy data for this indication are from a foreign single arm phase II clinical study on recurrent mantle cell lymphoma after previous treatment, but there is no clinical study data for Chinese population.
|